Rtw Investments, L.P. 13F annual report
Rtw Investments, L.P. is an investment fund managing more than $6.46 trillion ran by Roderick Wong. There are currently 67 companies in Mr. Wong’s portfolio. The largest investments include Madrigal Pharmaceuticals Inc and Rocket Pharmaceuticals Inc, together worth $918 billion.
$6.46 trillion Assets Under Management (AUM)
As of 7th August 2024, Rtw Investments, L.P.’s top holding is 1,915,862 shares of Madrigal Pharmaceuticals Inc currently worth over $537 billion and making up 8.3% of the portfolio value.
Relative to the number of outstanding shares of Madrigal Pharmaceuticals Inc, Rtw Investments, L.P. owns less than approximately 0.1% of the company.
In addition, the fund holds 17,687,772 shares of Rocket Pharmaceuticals Inc worth $381 billion, whose value fell 34.4% in the past six months.
The third-largest holding is Axsome Therapeutics Inc worth $373 billion and the next is Avidity Biosciences worth $360 billion, with 8,806,838 shares owned.
Currently, Rtw Investments, L.P.'s portfolio is worth at least $6.46 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Rtw Investments, L.P.
The Rtw Investments, L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Roderick Wong serves as the Managing Partner at Rtw Investments, L.P..
Recent trades
In the most recent 13F filing, Rtw Investments, L.P. revealed that it had opened a new position in
Cullinan Therapeutics Inc and bought 1,052,630 shares worth $18.4 billion.
The investment fund also strengthened its position in Madrigal Pharmaceuticals Inc by buying
1,518,815 additional shares.
This makes their stake in Madrigal Pharmaceuticals Inc total 1,915,862 shares worth $537 billion.
Madrigal Pharmaceuticals Inc soared 39.6% in the past year.
On the other hand, there are companies that Rtw Investments, L.P. is getting rid of from its portfolio.
Rtw Investments, L.P. closed its position in Avadel Pharmaceuticals plc on 14th August 2024.
It sold the previously owned 8,798,558 shares for $149 billion.
Roderick Wong also disclosed a decreased stake in Argenx Se by approximately 0.1%.
This leaves the value of the investment at $281 billion and 654,430 shares.
One of the largest hedge funds
The two most similar investment funds to Rtw Investments, L.P. are Stephens Inc ar/ and Mondrian Investment Partners Ltd. They manage $6.43 trillion and $6.5 trillion respectively.
Roderick Wong investment strategy
Rtw Investments, L.P.’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 80.6% of
the total portfolio value.
The fund focuses on investments in the United States as
52.2% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
6% of the total holdings value.
On the other hand, large-cap stocks make up only 1.5% of the portfolio.
The average market cap of the portfolio companies is close to $4.45 billion.
The complete list of Rtw Investments, L.P. trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc |
382.53%
1,915,862
|
$536,747,898,000 | 8.31% |
| Rocket Pharmaceuticals Inc |
No change
17,687,772
|
$380,817,731,000 | 5.90% |
| Axsome Therapeutics Inc |
3.15%
4,634,331
|
$373,063,646,000 | 5.78% |
| Avidity Biosciences, Inc. |
10.50%
8,806,838
|
$359,759,332,000 | 5.57% |
| Argenx Se |
1.91%
654,430
|
$281,431,077,000 | 4.36% |
| Natera Inc |
No change
2,593,323
|
$280,830,948,000 | 4.35% |
| Merus N.V |
1.46%
4,169,393
|
$246,702,984,000 | 3.82% |
| Insmed Inc |
95.17%
3,640,108
|
$243,887,236,000 | 3.78% |
| PTC Therapeutics Inc |
0.42%
7,393,127
|
$226,081,824,000 | 3.50% |
| Dyne Therapeutics, Inc. |
106.60%
6,387,138
|
$225,402,100,000 | 3.49% |
| Acadia Pharmaceuticals Inc |
0.88%
13,707,506
|
$222,746,973,000 | 3.45% |
| Bruker Corp |
2.99%
3,444,095
|
$219,767,702,000 | 3.40% |
| Masimo Corp |
No change
1,462,400
|
$184,174,656,000 | 2.85% |
| Protagonist Therapeutics Inc |
0.55%
5,286,404
|
$183,173,899,000 | 2.84% |
| Alkermes plc |
16.56%
7,056,988
|
$170,073,411,000 | 2.63% |
| Immunocore Hldgs Plc |
19.10%
4,869,798
|
$165,037,454,000 | 2.56% |
| Avadel Pharmaceuticals plc |
Closed
8,798,558
|
$148,607,645,000 | |
| Cytokinetics Inc |
7.77%
2,721,158
|
$147,432,340,000 | 2.28% |
| Ultragenyx Pharmaceutical In |
54.00%
3,259,927
|
$133,983,000,000 | 2.07% |
| Penumbra Inc |
9.80%
742,105
|
$133,556,637,000 | 2.07% |
| Akero Therapeutics Inc |
No change
5,431,985
|
$127,434,368,000 | 1.97% |
| Establishment Labs Holdings Inc |
No change
2,675,703
|
$121,583,944,000 | 1.88% |
| Immatics N.v |
No change
10,000,000
|
$116,200,000,000 | 1.80% |
| Stryker Corp. |
Closed
321,000
|
$114,876,270,000 | |
| Radnet Inc |
9.14%
1,856,010
|
$109,356,109,000 | 1.69% |
| Apogee Therapeutics Inc |
9.91%
2,712,096
|
$106,720,978,000 | 1.65% |
| Shockwave Med Inc |
Closed
288,684
|
$94,004,171,000 | |
| Tarsus Pharmaceuticals, Inc. |
4.28%
3,412,486
|
$92,751,369,000 | 1.44% |
| Intuitive Surgical Inc |
104.50%
202,456
|
$90,062,552,000 | 1.39% |
| Arvinas Inc |
10.01%
2,967,897
|
$79,005,418,000 | 1.22% |
| Spyre Therapeutics Inc |
45.93%
3,258,360
|
$76,604,044,000 | 1.19% |
| Cargo Therapeutics Inc |
9.17%
4,078,122
|
$66,962,763,000 | 1.04% |
| Thermo Fisher Scientific Inc. |
Closed
110,500
|
$64,223,705,000 | |
| UroGen Pharma Ltd |
9.21%
3,557,347
|
$59,692,283,000 | 0.92% |
| Sage Therapeutics Inc |
No change
5,480,577
|
$59,519,066,000 | 0.92% |
| 89bio Inc |
No change
7,378,548
|
$59,102,169,000 | 0.92% |
| Stoke Therapeutics, Inc. |
No change
4,224,838
|
$57,077,561,000 | 0.88% |
| Orchestra Biomed Hldgs Inc |
No change
5,620,640
|
$45,808,216,000 | 0.71% |
| Glaukos Corporation |
557.06%
386,291
|
$45,717,540,000 | 0.71% |
| Cg Oncology Inc |
224.91%
1,344,074
|
$42,432,416,000 | 0.66% |
| Taysha Gene Therapies, Inc. |
1.11%
18,800,299
|
$42,112,670,000 | 0.65% |
| Neurogene Inc |
39.19%
1,070,565
|
$38,957,860,000 | 0.60% |
| Gh Research Plc |
No change
3,327,129
|
$38,794,324,000 | 0.60% |
| Janux Therapeutics Inc |
Closed
1,000,000
|
$37,650,000,000 | |
| Vericel Corp |
50.11%
801,397
|
$36,768,094,000 | 0.57% |
| Fulcrum Therapeutics Inc |
No change
5,845,956
|
$36,244,927,000 | 0.56% |
| Cullinan Therapeutics Inc |
Opened
1,052,630
|
$18,357,867,000 | 0.28% |
| Dianthus Therapeutics Inc |
No change
666,667
|
$17,253,342,000 | 0.27% |
| Roivant Sciences Ltd |
No change
1,454,273
|
$15,371,666,000 | 0.24% |
| Lenz Therapeutics Inc |
No change
863,389
|
$14,927,996,000 | 0.23% |
| Tempus Ai Inc |
Opened
400,000
|
$14,000,000,000 | 0.22% |
| Kyverna Therapeutics Inc |
No change
1,852,711
|
$13,895,333,000 | 0.22% |
| Essa Pharma Inc |
No change
2,298,662
|
$12,090,962,000 | 0.19% |
| Replimune Group Inc |
Opened
1,133,787
|
$10,204,083,000 | 0.16% |
| 10x Genomics, Inc. |
67.66%
502,856
|
$9,780,549,000 | 0.15% |
| Tourmaline Bio Inc |
No change
741,656
|
$9,537,696,000 | 0.15% |
| Viridian Therapeutics Inc |
No change
605,816
|
$7,881,666,000 | 0.12% |
| Perceptive Cap Solutions Cor |
Opened
742,500
|
$7,469,550,000 | 0.12% |
| Exact Sciences Corp. |
Closed
95,000
|
$6,560,700,000 | |
| ARCA biopharma Inc |
Opened
1,400,000
|
$5,362,000,000 | 0.08% |
| Immunic, Inc. |
No change
4,567,717
|
$5,070,166,000 | 0.08% |
| Larimar Therapeutics, Inc. |
Closed
650,000
|
$4,933,500,000 | |
| Structure Therapeutics Inc |
Opened
125,000
|
$4,908,750,000 | 0.08% |
| Acelyrin Inc |
No change
978,310
|
$4,314,347,000 | 0.07% |
| Milestone Pharmaceuticals In |
No change
3,256,102
|
$4,298,055,000 | 0.07% |
| Regenxbio Inc |
No change
350,000
|
$4,095,000,000 | 0.06% |
| Allurion Technologies Inc |
6.94%
3,697,549
|
$3,688,675,000 | 0.06% |
| Exagen Inc |
0.48%
1,511,866
|
$2,751,596,000 | 0.04% |
| Sab Biotherapeutics Inc |
16.44%
766,946
|
$2,377,533,000 | 0.04% |
| Beyond Air, Inc. |
Closed
1,204,820
|
$2,096,387,000 | |
| Cutera Inc |
No change
1,331,776
|
$2,010,982,000 | 0.03% |
| Sagimet Biosciences Inc |
49.96%
500,000
|
$1,710,000,000 | 0.03% |
| Arya Sciences Acqu Corp Iv |
No change
127,970
|
$1,467,816,000 | 0.02% |
| CytomX Therapeutics Inc |
Opened
1,200,002
|
$1,464,002,000 | 0.02% |
| Adicet Bio Inc |
74.52%
1,053,688
|
$1,274,962,000 | 0.02% |
| No transactions found | |||
| Showing first 500 out of 75 holdings | |||
Hedge funds similar to Rtw Investments, L.P.
- Bartlett & Co. Wealth Management
- Illinois Municipal Retirement Fund
- Rothschild & Co Asset Management Us Inc
- Bellevue Ag
- Phoenix
- Trexquant Investment L.P.
- Mondrian Investment Partners Ltd
- Stephens Inc ar/
- Smead Capital Management
- Evercore Wealth Management
- Mather Group,
- Timessquare Capital Management
- Lgt Foundation
- Pinnacle Associates Ltd